Nanotoxicology
Note: The following journal information is for reference only. Please check the journal website for updated information prior to submission.
Journal Title
Nanotoxicology
NANOTOXICOLOGY
ISSN / eISSN
1743-5390 / 1743-5404
Aims and Scope
Nanotoxicology invites contributions addressing research relating to the potential for human and environmental exposure, hazard and risk associated with the use and development of nano-structured materials. In this context, the term nano-structured materials has a broad definition, including ‘materials with at least one dimension in the nanometer size range’. These nanomaterials range from nanoparticles and nanomedicines, to nano-surfaces of larger materials and composite materials. The range of nanomaterials in use and under development is extremely diverse, so this journal includes a range of materials generated for purposeful delivery into the body (food, medicines, diagnostics and prosthetics), to consumer products (e.g. paints, cosmetics, electronics and clothing), and particles designed for environmental applications (e.g. remediation). It is the nano-size range if these materials which unifies them and defines the scope of Nanotoxicology .
While the term ‘toxicology’ indicates risk, the journal Nanotoxicology also aims to encompass studies that enhance safety during the production, use and disposal of nanomaterials. Well-controlled studies demonstrating a lack of exposure, hazard or risk associated with nanomaterials, or studies aiming to improve biocompatibility are welcomed and encouraged, as such studies will lead to an advancement of nanotechnology. Furthermore, many nanoparticles are developed with the intention to improve human health (e.g. antimicrobial agents), and again, such articles are encouraged. In order to promote quality, Nanotoxicology will prioritise publications that have demonstrated characterisation of the nanomaterials investigated.
While the term ‘toxicology’ indicates risk, the journal Nanotoxicology also aims to encompass studies that enhance safety during the production, use and disposal of nanomaterials. Well-controlled studies demonstrating a lack of exposure, hazard or risk associated with nanomaterials, or studies aiming to improve biocompatibility are welcomed and encouraged, as such studies will lead to an advancement of nanotechnology. Furthermore, many nanoparticles are developed with the intention to improve human health (e.g. antimicrobial agents), and again, such articles are encouraged. In order to promote quality, Nanotoxicology will prioritise publications that have demonstrated characterisation of the nanomaterials investigated.
Subject Area
TOXICOLOGY
NANOSCIENCE & NANOTECHNOLOGY
CiteScore
10.20
View Trend
CiteScore Ranking
| Category | Quartile | Rank |
|---|---|---|
| Pharmacology, Toxicology and Pharmaceutics - Toxicology | Q1 | #10/124 |
| Pharmacology, Toxicology and Pharmaceutics - Biomedical Engineering | Q1 | #35/277 |
Web of Science Core Collection
| Science Citation Index Expanded (SCIE) | Social Sciences Citation Index (SSCI) |
|---|---|
| Indexed | - |
| Category (Journal Citation Reports 2023) | Quartile |
|---|---|
| NANOSCIENCE & NANOTECHNOLOGY - SCIE | Q2 |
| TOXICOLOGY - SCIE | Q1 |
H-index
72
Country/Area of Publication
ENGLAND
Publisher
Informa Healthcare
Publication Frequency
Quarterly
Year Publication Started
2007
Annual Article Volume
55
Open Access
NO
Contact
INFORMA HEALTHCARE, 52 VANDERBILT AVE, NEW YORK, USA, NY, 10017
Verified Reviews
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started